Aberdeen Standard Physical Swiss Gold Shares ETF (NYSEARCA:SGOL)

newspaper

Media Digest 7/31/2009 Reuters, WSJ, NYTimes, FT, Bloomberg

Reuters:   Banks paid out billions of dollars in bonuses last year while losing money. Reuters:   The US closed  its car "clunkers" program just as it began as funds ran out. ...
Read Full Story »
Money Stack Image

DJIA Component Earnings Trifecta (DD, MRK, UTX)

So far we have three DJIA components with earnings out.  DuPont (NYSE: DD), Merck & Co. (NYSE: MRK), United Technologies (NYSE: UTX) have all posted earnings.  So far there are ...
Read Full Story »
money-stack-image52

Allergan May Join Sector Takeover Waves (AGN, GSK, DNA, PFE, WYE, MRK, SGP)

If the rumor mill has any truth to it, then Allergan Inc. (NYSE: GSK) may by the next biotech takeover target.  There is roughly $150 billion in new equity investor ...
Read Full Story »
cammonopoly_wideweb__430x32506

Merck’s (MRK) New Merger, Another Way To Save Money

Merck (MRK) is merging with Schering-Plough (SGP) in a deal that the companies say is worth $41.1  billion. In reality, Merck is making an acquisition. Its shares will be the ...
Read Full Story »
bill-gates-image

Bill Gates Top Holdings (ABT, AN, BRK-A, BP, CNI, CAT, KO, COST, CCI, EK, XOM, FMX, JNJ, MCD, OTTR, RSG, SGP, WMT, WMI)

We compiled a list of the equity holdings of the Bill & Melinda Gates Foundation and for Bill Gates' personal investment vehicle Cascade Investment.  These are as of December 31, ...
Read Full Story »
Money_stack_pic

Is Pfizer About To Be On Acquisition Path? (PFE, AMGN, WYE, GILD, BMY, LLY, SGP, CELG, GENZ, BIIB)

There may be some speculation that drug giant Pfizer Inc. (NYSE: PFE) is looking at expansion through acquisitions.  The FT reported that the world's largest pharmaceutical company is willing to ...
Read Full Story »

Top Pre-Market Analyst Downgrades (ADBE, AGU, CMI, INTU, MOS, NST, PENN, CRM, SCG, SGP, SYMC, TEX, XRTX)

These are the top analyst downgrade calls we are seeing this Friday morning with two hours to the open:Adobe Systems (ADBE) Cut to Sell at UBS.Agrium (AGU) Cut to Hold ...
Read Full Story »
Angrybear

A Dozen Companies Which Should Lay-Off 10,000 People This Year

The evidence that sales at many companies are struggling and that employment will suffer are almost everywhere. Recently, a division of GMAC said it would let 5,000 people go. According ...
Read Full Story »
R218533_855025_2

More Blight For Merck (MRK)

Merck (MRK) and Schering-Plough (SGP) make two of the most widely sold drugs in the world. One is cholesterol drug Zetia. Another is a related drug called Vytorin. The sales ...
Read Full Story »

Top Pre-Market Analyst Upgrades (EHTH, FFIV, FDRY, LEN, OXPS, SGP, TWTI)

These are some of the top upgrades or positive analyst calls we have seen this Tuesday morning in early pre-market trading hours:eHealth (NASDAQ: EHTH) Raised to Perform from Underperform at ...
Read Full Story »

The Whining From Drug Companies: The FDA Is Hard On Us

The profit-mongering Big Pharma companies don't want the FDA to take so long approving their drugs. It cuts into profits and delays their chances of making money on new blockbuster ...
Read Full Story »

The 52-Week Low Club (SGP)(PAY)(DEEP)

Superior Offshore (DEEP) Company warns of liquidity problems. Down to $1.20 from 52-week high of $19.58.Medarex (MEDX) Pfizer ends joint drug trial. Sells off to $7.44 from 52-week high of ...
Read Full Story »

Media Digest 4/1/2008 Reuters, WSJ, NYTimes, FT, Bloomberg

According to Reuters, US car sales for March are likely to be off sharply.Reuters writes that Microsoft (MSFT) will not raise its bid for Yahoo!  (YHOO)Reuters reports that UBS (UBS) ...
Read Full Story »

Big Price Movers In S&P 500 For Q1 2008 (MSFT)(GOOG)(AAPL)(INTC)(C)(AIG)(VZ)

The largest losers among the big companies in the S&P 500 for the first quarter were:Microsoft (MSFT) down 21.6%, Google (GOOG) down 36.7%, Apple (AAPL) down 27.8%, Intel (INTC) down ...
Read Full Story »

The 52-Week Low Club (SGP)(MRK)(MO)

Schering-Plough (SGP) Bad news on key cholesterol drug marketed with Merck. Shares fall to $14 from 52-week high of $33.81.Merck (MRK) Pulled down for the same reason. Sells off to ...
Read Full Story »